news releases

news releases
BURCON ANNOUNCES YEAR-END RESULTS, UPDATES ON ACTIVITIES

Vancouver, British Columbia, June 28, 2010 — Burcon NutraScience Corporation (TSX – BU) (“Burcon”) today reported financial results for the fiscal year ended March 31, 2010 and provided a review of the year’s operations.

A summary of the highlights of the past year includes:

  • Raised gross proceeds of $16.9 million through a public offering of 2,942,950 common shares at $5.75 per share in June 2009;

  • Graduated to the Toronto Stock Exchange (“TSX”) on June 18, 2009;

  • Obtained publication in peer-reviewed journals of research reports summarizing the design and conclusions of the toxicology studies conducted on Puratein® and Supertein™ canola protein isolates;

  • Filed a formal GRAS notification with the U.S. Food and Drug Administration (‘FDA”) in January 2010 in support of a cruciferin-rich canola protein isolate: Puratein® and a napin-rich canola protein isolate: Supertein™;

  • Entered into materials transfer agreements (“MTAs”) and non-disclosure agreements (“NDAs”) with a number of globally recognized food, beverage and nutritional product companies to evaluate CLARISOY® soy protein isolate for the purpose of pursuing a strategic alliance;

  • Held discussions, supported due diligence activities, and negotiated possible business structures with various entities for the commercialization of CLARISOY® soy protein isolate. These activities are ongoing as of the date of this news release;

  • Completed a pre-feasibility study for the construction and commissioning of an initial CLARISOY® production facility;

  • Filed several patent applications over newly developed novel processes for the production, functional and nutritional applications of, and functional attributes of CLARISOY® soy protein isolate;

  • Filed several patent applications over new inventions on the production of canola protein isolates;

  • Received notices of allowances from the U.S. Patent and Trademark Office on ten separate patent applications filed on our canola protein isolate extraction technology, of which five have proceeded to grant as United States patents;

  • Appointed three independent directors; and

  • Raised $446,000 through the exercise of incentive stock options and agents’ compensation options.

 

   To view the rest of this News Release click here.